Pharmacist Moms Group^™

Dr Schrade discusses the impact of prophylactic treatment for patients with hemophilia A.

The panel of experts provide their closing thoughts, highlighting unmet needs and treatments on the horizon for MDS.

Drs Mancini and Mahmoudjafari discuss NCCN Guidelines affecting treatment strategies for patients with MDS.

Luke Gormley, PharmD, BCPS, discusses how pharmacists are involved in the management of inclisiran.

A panel of experts explore burdens facing patients diagnosed with RRMM.

Ryan Haumschild, PharmD, MS, MBA, leads a panel surrounding individualized strategies for treating patients with relapse/refractory (RR) MM.

Dr Mahmoudjafari highlights the changing treatment landscape for patients with CLL.

Sarah McDonald, cancer survivor and author of The Cancer Channel, discusses her experience battling 2 different unrelated cancers and the value oncology pharmacists could have provided with a greater presence on her care team.

Atta Chowdhry, RPh, shares his final thoughts regarding the trajectory of hemophilia treatment strategies.